Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Exclusion Criteria

• •Subject has developed hypersensitivity to any components of the investigational medicinal product (IMP) or comparative drugs as stated in this protocol during the course of the core studies
• •Severe medical, neurological, or psychiatric disorders, or laboratory values which may have an impact on the safety of the subject
• •Poor compliance with the visit schedule or medication intake in the previous BRV study
• •Planned participation in any other clinical study of another investigational drug or device during this study
• •Pregnant or lactating woman
• •Any medical condition which, in the Investigator's opinion, warrants exclusion
• •Subject has a lifetime history of suicide attempt or has suicidal ideation in the past 6 months